These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34662447)

  • 21. Glutathione Peroxidase 3 Inhibits Prostate Tumorigenesis in TRAMP Mice.
    Chang SN; Lee JM; Oh H; Park JH
    Prostate; 2016 Nov; 76(15):1387-98. PubMed ID: 27325372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
    Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
    Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
    Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK
    Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.
    Couto SS; Cao M; Duarte PC; Banach-Petrosky W; Wang S; Romanienko P; Wu H; Cardiff RD; Abate-Shen C; Cunha GR
    Differentiation; 2009 Jan; 77(1):103-11. PubMed ID: 19281769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine uptake and prostate cancer in the TRAMP mouse model.
    Olvera-Caltzontzin P; Delgado G; Aceves C; Anguiano B
    Mol Med; 2013 Nov; 19(1):409-16. PubMed ID: 24306422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
    Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
    Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z
    J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
    Tepaamorndech S; Huang L; Kirschke CP
    Cancer Lett; 2011 Sep; 308(1):33-42. PubMed ID: 21621325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobe-specific proteome changes in the dorsal-lateral and ventral prostate of TRAMP mice versus wild-type mice.
    Zhang J; Wang L; Zhang Y; Li L; Higgins L; Lü J
    Proteomics; 2011 Jun; 11(12):2542-9. PubMed ID: 21598396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
    Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
    Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective serum metabolomic profiling of lethal prostate cancer.
    Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
    Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The protein kinase C super-family member PKN is regulated by mTOR and influences differentiation during prostate cancer progression.
    Yang CS; Melhuish TA; Spencer A; Ni L; Hao Y; Jividen K; Harris TE; Snow C; Frierson HF; Wotton D; Paschal BM
    Prostate; 2017 Nov; 77(15):1452-1467. PubMed ID: 28875501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.
    Svensson RU; Haverkamp JM; Thedens DR; Cohen MB; Ratliff TL; Henry MD
    Am J Pathol; 2011 Jul; 179(1):502-12. PubMed ID: 21703427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.
    Zhang J; Wang L; Anderson LB; Witthuhn B; Xu Y; Lü J
    Cancer Prev Res (Phila); 2010 Aug; 3(8):994-1006. PubMed ID: 20647336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
    Maxwell PJ; Coulter J; Walker SM; McKechnie M; Neisen J; McCabe N; Kennedy RD; Salto-Tellez M; Albanese C; Waugh DJ
    Eur Urol; 2013 Aug; 64(2):177-88. PubMed ID: 22939387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2.
    Gupta A; Yu X; Case T; Paul M; Shen MM; Kaestner KH; Matusik RJ
    Prostate; 2013 May; 73(6):582-9. PubMed ID: 23060003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR.
    Simper NB; Jones CL; MacLennan GT; Montironi R; Williamson SR; Osunkoya AO; Wang M; Zhang S; Grignon DJ; Eble JN; Tran T; Wang L; Baldrige LA; Cheng L
    Hum Pathol; 2015 Jun; 46(6):805-12. PubMed ID: 25870120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.
    Zhang J; Wang L; Zhang Y; Li L; Tang S; Xing C; Kim SH; Jiang C; Lü J
    Mol Carcinog; 2015 Dec; 54(12):1567-83. PubMed ID: 25307620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.